- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00310141
Computer-Assisted Counseling in Helping African American Smokers Stop Smoking
Treatment of Nicotine Dependence Among African Americans
RATIONALE: Stop-smoking plans using a nicotine patch, in-person counseling, and computer-assisted counseling may help people stop smoking.
PURPOSE: This randomized clinical trial is studying how well computer-assisted counseling helps African American smokers stop smoking.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
OBJECTIVES:
- Develop and evaluate the efficacy of an interactive, culturally sensitive, individualized, palmtop computer-delivered smoking cessation intervention for African American smokers.
- Examine how hypothesized treatment mechanisms mediate the effects of computer-delivered treatment on abstinence.
OUTLINE: This is a randomized study. A subset of 20 participants are assigned to arm II for pilot testing. All other participants are randomized to 1 of 2 intervention arms.
- Arm I (standard care [SC]): Participants receive nicotine patch therapy on days -5 to 31. Participants also receive a Pathways to Freedom self-help guide and undergo 5 in-person counseling sessions based on the Treating Tobacco Use and Dependence Clinical Practice Guideline. The counseling sessions occur at 12 and 5 days prior to the quit smoking date and at 3, 10, and 31 days after the quit smoking date.
- Arm II (computer-delivered treatment [CDT]): Participants receive the same intervention as in arm I. Participants also undergo CDT for 6 weeks comprising 5 modules (quitting strategies; motivation and support; general smoking information; calendars and fun stuff; and daily tips) beginning 12 days prior to the quit smoking date and continuing for 31 days after the quit smoking date.
All participants complete questionnaires at baseline, during the counseling sessions, and then at approximately 6 months after the quit smoking date.
After completion of study intervention, participants are followed at approximately 6 months.
PROJECTED ACCRUAL: A total of 500 participants will be accrued for this study.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Texas
-
Houston, Texas, Forente stater, 77030-4009
- University of Texas MD Anderson Cancer Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- African American
- Age 21 to 65 years
- Current Smoker (history of at least 5 cigarettes/day for the last year)
- Motivated to quit within the next 14 days
- Participants must provide a viable home address and functioning home telephone number
- Can speak, read, write in English at a sixth-grade literacy level
- Provide viable collateral contact information
- Register "8" or more on a carbon monoxide breath test
Exclusion Criteria:
- Contraindication for nicotine patch use
- Active substance dependence (exclusive of nicotine dependence)
- Regular use of tobacco products other than cigarettes (cigars, pipes, smokeless)
- Use of bupropion or nicotine products other than nicotine patches supplied by the study
- Pregnancy or lactation
- Any active illness that precludes full participation in the study protocol
- Another household member enrolled in the study
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: Standard Care Group
Written self-help materials, counseling, and 6-week nicotine patch supply
|
In-person counseling (5 sessions)
6-week supply of the nicotine patch
|
Aktiv komparator: Computer Treatment Group (CDT)
Written self-help materials, counseling, 6-week nicotine patch supply and 6 weeks of computer-delivered treatment
|
In-person counseling (5 sessions)
6-week supply of the nicotine patch
6 weeks of computer delivered treatment for quitting smoking
|
Eksperimentell: CDT Pilot
Written self-help materials, counseling, 6-week nicotine patch supply and 6 weeks of computer-delivered treatment
|
In-person counseling (5 sessions)
6-week supply of the nicotine patch
6 weeks of computer delivered treatment for quitting smoking
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Smoking status by SRNT Smoking Status Questionnaire 6 months after treatment
Tidsramme: 6 months after treatment
|
Abstinence measures are collected at four post cessation follow-up visits.
Point prevalence serving as the primary outcome measure.
Primary outcome analyses will use data from all of the follow-up visits.
SRNT Abstinence Status Questionnaire (Hughes et al., 2003) surveys the tobacco use by the participant and persons within the participant's household and social surroundings.
The questionnaire also collects data on the use of other tobacco products and nicotine replacement medications.
The pre- and post-quit versions of this questionnaire have been adapted to specific timepoints corresponding to participant visits.
|
6 months after treatment
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Contemplating smoking by Contemplation Ladder 6 months after treatment
Tidsramme: 6 months after treatment
|
The Contemplation Ladder (Biener & Abrams, 1991) assesses readiness to quit smoking and ranges from 0-10 with 0 being "no thought of quitting" and 10 being "taking action to quit" (e.g., cutting down, enrolling in a program).
|
6 months after treatment
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Studiestol: David W. Wetter, PhD, MS, M.D. Anderson Cancer Center
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Sykdommer i luftveiene
- Neoplasmer
- Lungesykdommer
- Neoplasmer etter nettsted
- Neoplasmer i luftveiene
- Thoracale neoplasmer
- Lungeneoplasmer
- Fysiologiske effekter av legemidler
- Nevrotransmittere agenter
- Molekylære mekanismer for farmakologisk virkning
- Autonome agenter
- Agenter fra det perifere nervesystemet
- Kolinerge midler
- Ganglioniske stimulerende midler
- Nikotiniske agonister
- Kolinerge agonister
- Nikotin
Andre studie-ID-numre
- ID01-234
- P30CA016672 (U.S. NIH-stipend/kontrakt)
- R01CA094826 (U.S. NIH-stipend/kontrakt)
- MDA-ID-01234 (Annen identifikator: UT MD Anderson Cancer Center)
- CDR0000466339 (Registeridentifikator: NCI PDQ)
- NCI-2012-01637 (Registeridentifikator: NCI CTRP)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Lungekreft
-
Yonsei UniversityFullført
-
Novartis PharmaceuticalsFullførtNevroendokrine svulster | Avansert NET av GI Origin | Advanced NET of Lung OriginForente stater, Colombia, Italia, Taiwan, Storbritannia, Belgia, Tsjekkia, Tyskland, Japan, Saudi-Arabia, Canada, Nederland, Spania, Korea, Republikken, Libanon, Østerrike, Kina, Hellas, Sør-Afrika, Thailand, Ungarn, Tyrkia, Polen, Slov... og mer
-
The Cleveland ClinicTilbaketrukketOne Lung Ventillation (OLV) | To lungeventilasjon (TLV) | Positivt End Expiratory Pressure (PEEP) | Null sluttekspirasjonstrykk (ZEEP)
-
Assiut UniversityHar ikke rekruttert ennåLungekreft | Lungeskade | Bleb Lung
-
RenJi HospitalRekrutteringMultiple Synchronous Lung Cancers (MSLC)Kina
-
Poitiers University HospitalFullførtEndobronchial Transbronchial Needle Aspiration Lung Cancer Procore
-
University of LorraineFullførtBare barn | Spontan pneumothorax | Idiopatisk pneumotoraks | Bleb LungFrankrike
-
AHS Cancer Control AlbertaCross Cancer InstituteFullførtOmfattende Stage Small Cel Lung CancerCanada
-
Damascus UniversityUniversity Children's HospitalFullførtEsophageal atresi | One Lung Ventilation OLV | Hydrocystoma | Pneumonektomi | Pleura; AbscessDen syriske arabiske republikk
-
Ministry of Health, Saudi ArabiaHar ikke rekruttert ennåLuftveissykdom | Prematuritet | Ventilator Lung; Nyfødt
Kliniske studier på Counseling intervention
-
Northwestern UniversityGeorgetown UniversityPåmelding etter invitasjonKroniske nyresykdommer | Genetisk predisposisjonForente stater
-
University of PennsylvaniaAbramson Cancer Center of the University of PennsylvaniaFullført
-
The University of Tennessee, KnoxvilleColorado State UniversityAktiv, ikke rekrutterendeCannabisbruksforstyrrelse, mild | Cannabisbruksforstyrrelse, moderat | Cannabisbruksforstyrrelse, alvorligForente stater
-
University of California, BerkeleyNational Institute of Mental Health (NIMH); Ministry of Health, Tanzania; Management and Development for Health og andre samarbeidspartnereRekruttering
-
Montefiore Medical CenterNational Institute of Mental Health (NIMH); Albert Einstein College of... og andre samarbeidspartnereAvsluttetHIV/AIDS | Overholdelse, pasient | GruppemøterForente stater
-
Texas Christian UniversityAktiv, ikke rekrutterendeKartleggingsmetoder for å forberede implementeringsoverføring | Behandlingsberedskap og induksjonsprogramForente stater
-
Case Western Reserve UniversityAmerican UniversityHar ikke rekruttert ennåErnæring, sunn
-
Thomas Jefferson UniversityRekrutteringProstata karsinomForente stater
-
University of TartuState University of New York - Downstate Medical Center; Tibotec Pharmaceutical...FullførtErvervet immunsviktsyndrom | Medisinoverholdelse | Akutt HIV-infeksjonEstland
-
University of Massachusetts, AmherstUniversity of California, San Francisco; RAND; Universidad Autonoma de Santo... og andre samarbeidspartnereHar ikke rekruttert ennå